MGI and King Abdullah International Medical Research Center Announce Partnership for Genomic Research

The new agreement will enable cutting-edge research aimed at preventing disease and improving health while supporting specialized training of healthcare professionals and scientists.
 
Saudi Arabia, gulftech — Global life science innovator MGI Tech Co. Ltd. (MGI) and King Abdullah International Medical Research Center (KAIMRC) have signed a Memorandum of Understanding (MOU) to engage in a strategic collaboration in the fields of genomic science and biotechnology.
 
MGI and KAIMRC will lead an international collaborative research program powered by MGI’s innovative technologies in areas such as genomics and bioinformatics for health and diseases while driving the development of local talent in these fields.
 
Driven by MGI’s proprietary DNBSEQ™ technology, the strategic collaboration will utilize MGI’s platform to improve genome sequencing and data quality across a wide range of applications, including human genome sequencing, transcriptome sequencing, infectious diseases, and microbial organisms research, such as COVID-19 monitoring and epidemiology.   The MOU envisions the establishment of a high-throughput sequencing center in KAIMRC which will house MGI’s leading technology platforms, including DNBSEQ™ sequencing, laboratory automation, and bioinformatics products. As part of the collaboration, MGI and KAIMRC will also join forces across several other areas such as business development, marketing, and public communications, and education to enhance genomic research and development, as well as create the awareness in the coming genomic era.
 
Commenting on the collaboration, Prof. Ahmed Alaskar, Executive Director, KAIMRC said: “MGI is an invaluable strategic partner in our journey towards establishing state-of-the-art genomic sequencing capabilities in Saudi Arabia. Precision medicine is the future of healthcare and this partnership paves the way for new and innovative approaches in this field.”
 
Dr. Roy Tan, General Manager of MGI Asia Pacific said: ” We are extremely proud and excited to partner with KAIMRC on this important initiative aimed at improving people’s health. We look forward to integrating our expertise with KAIMRC to deliver a positive impact on health and wellness that will benefit not only just Saudi Arabia but also the rest of the world.”
 
Established in 2016, MGI is a leading innovator in life sciences. Employing over 1,700 employees worldwide, MGI operates in more than 70 countries and regions, serving more than 1,000 customers with world-class products and services. MGI innovative products include Genetic Sequencer*, Laboratory Automation System, and Robotic Ultrasound System, supporting customers globally in life science research, medicine and healthcare.